Turkish Journal of Nephrology
Original Article

Current Status of Renal Replacement Therapies in Turkey: Turkish Society of Nephrology Registry 2014 Summary Report

1.

İstanbul Üniversitesi, Cerrahpaşa Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Nefroloji Bilim Dalı, İstanbul, Türkiye

2.

Ankara Üniversitesi, Ankara Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Nefroloji Bilim Dalı, Ankara, Türkiye

3.

Akdeniz Üniversitesi, Akdeniz Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Nefroloji Bilim Dalı, Antalya, Türkiye

Turkish J Nephrol 2016; 25: 135-141
DOI: 10.5262/tndt.2016.1002.02
Read: 582 Downloads: 280 Published: 05 February 2019

OBJECTIVE: The Turkish Society of Nephrology registry collects data on hemodialysis, peritoneal dialysis and transplantation on an annual basis. Registry reports are printed every year as a booklet and this is the 25th year of registry reports. The registry is in close collaboration with international registries.

MATERIAL and METHODS: In this paper, data from the 2014 registry report are summarized and additionally yearly trends in the management of end-stage renal disease are also provided.

RESULTS: The number of patients on renal replacement therapy is increasing. At the end of 2014, 71.318 patients were on renal replacement therapy. The prevalence and incidence of end-stage renal disease was 918 and 147 per million population respectively. Diabetes was the most important cause of end-stage renal disease. Hemodialysis (78.4%) was the most common type of treatment modality, followed by transplantation (15.6%) and peritoneal dialysis (6.0%).

CONCLUSION: End-stage kidney disease is a very important and growing health problem for our country. The renal registry is a leading tool for providing current and sound data on this public health problem.

Files
EISSN 2667-4440